Ming Capital
Shenzhenmingcapital.cn
Overview
Ming Capital is a global healthcare venture capital firm that supports global medical breakthroughs, especially in innovative medicine, medical devices, and IVD.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AlloyX | Jan 2025 | Seed | Co-investor |
| Binhui Biopharmaceutical Co., Ltd. | Apr 2022 | Series B Extension | Co-investor |
| Wuhan Binhui Biopharmaceutical Co., Ltd. | Apr 2022 | Series B Extension | Co-investor |
| Eureka Bio | Apr 2021 | Series A | Co-investor |
| Caretaker Medical | Jun 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
